A cross-sectional study was performed on 48 psoriasis Vietnamese patients treated with metformin as an add-on for methotrexate and 48 psoriasis patients treated methotrexate alone. The mean PASI scores were 5.25 ± 5.72. Total QOL scores had a slight difference between patients treated metformin combined with methotrexate and methotrexate alone (62.32 ± 18.1 vs 60.91 ± 19.63). Combined therapy with metformin and methotrexate contributes to significantly improve the quality of life for patients with psoriasis.
Quality of Life in Psoriasis Vietnamese Patients Treated with Metformin in Combination with Methotrexate / Xuan, Tam Huynh Thi; Thi, Van Bui; Ngoc, Anh Tran; Van, Em Dang; Dang, Quyet Tran; Van, Thuong Nguyen; Minh, Phuong Pham Thi; Thi, Lan Pham; Huu, Nghi Dinh; Gandolfi, Marco; Satolli, Francesca; Feliciani, Claudio; Tirant, Michael; Vojvodic, Aleksandra; Lotti, Torello. - In: OPEN ACCESS MACEDONIAN JOURNAL OF MEDICAL SCIENCES. - ISSN 1857-9655. - 7:2(2019), p. 302-303. [10.3889/oamjms.2019.066]
Quality of Life in Psoriasis Vietnamese Patients Treated with Metformin in Combination with Methotrexate
Gandolfi, MarcoWriting – Review & Editing
;Satolli, FrancescaMembro del Collaboration Group
;Feliciani, ClaudioMembro del Collaboration Group
;
2019-01-01
Abstract
A cross-sectional study was performed on 48 psoriasis Vietnamese patients treated with metformin as an add-on for methotrexate and 48 psoriasis patients treated methotrexate alone. The mean PASI scores were 5.25 ± 5.72. Total QOL scores had a slight difference between patients treated metformin combined with methotrexate and methotrexate alone (62.32 ± 18.1 vs 60.91 ± 19.63). Combined therapy with metformin and methotrexate contributes to significantly improve the quality of life for patients with psoriasis.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
